Brivaracetam is an anticonvulsant medication indicated for the treatment of partial-onset seizures in patients aged one month and older. It works by modulating synaptic transmission and stabilizing neuronal activity, effectively reducing the frequency of seizures. Its clinical significance lies in its ability to provide effective seizure control, improving the quality of life for individuals with epilepsy. In summary, Brivaracetam is essential for managing partial-onset seizures.
Brivaracetam binds to the synaptic vesicle protein 2A, inhibiting excessive neurotransmitter release and stabilizing neuronal excitability.
No published brands for this salt yet.